Antineoplastic Protocols
Mostrando 1-10 de 10 artigos, teses e dissertações.
-
1. Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
Abstract Background: Mucocutaneous adverse events are common during anticancer treatment, with variable consequences for the patient and their therapeutic regimen. Objective: To evaluate the most common adverse events, as well as the drugs associated with their appearance and the consequences for cancer treatment. Methods: A retrospective study was carrie
Anais Brasileiros de Dermatologia. Publicado em: 2022
-
2. Severe oral mucositis relating to pain and worse oral condition among patients with solid tumors undergoing treatment with FOLFIRI and 5-FU: a retrospective study
ABSTRACT BACKGROUND: There is a need for studies that correlate the severity of oral mucositis (OM) with chemotherapy protocols, transient myelosuppression and oral health. OBJECTIVE: To analyze the severity of OM among individuals with solid tumors during hospitalization and its correlation with the type of chemotherapy, myelosuppression and oral health c
Sao Paulo Medical Journal. Publicado em: 2022
-
3. PATIENT SAFETY IN THE ADMINISTRATION OF ANTINEOPLASTIC CHEMOTHERAPY AND OF IMMUNOTHERAPICS FOR ONCOLOGICAL TREATMENT: SCOPING REVIEW
RESUMO Objetivo: identificar e sintetizar as evidências científicas sobre segurança do paciente oncológico na administração de quimioterápicos antineoplásicos e imunoterápicos. Método: scoping review, conforme Joanna Briggs Institute e as recomendações do guia internacional PRISMA-ScR. Realizou-se pesquisa em cinco bases de dados eletrônicas,
Texto contexto - enferm.. Publicado em: 04/11/2019
-
4. Acompanhamento por telefone como intervenção de enfermagem a pacientes em quimioterapia ambulatorial: revisão integrativa
Resumo OBJETIVO Conhecer a produção científica sobre o acompanhamento por telefone feito pelo enfermeiro junto a pacientes oncológicos em quimioterapia ambulatorial. MÉTODO Revisão integrativa de artigos disponíveis nas bases de dados LILACS e BDENF/BVS, MEDLINE/PubMed, CINAHL e Scopus utilizando os descritores: “Drug Therapy”, “Antineoplastic
Rev. Gaúcha Enferm.. Publicado em: 23/09/2019
-
5. Epidemiological aspects, biotipologia and evolution of the treatment of acute lymphocytic leukemia in childhood and adolescence in Rio Grande do Sul / Aspectos epidemiológicos, biotipologia e evolução do tratamento da leucemia linfocítica aguda na infância e adolescência no Rio Grande do Sul
A Leucemia Linfocítica Aguda na infância e adolescência é uma neoplasia de precursores linfóides de natureza heterogênea. Foi a primeira neoplasia disseminada a tornar-se curável pela quimioterapia. No Brasil os estudos cooperativos para o seu tratamento foram iniciados em 1980 com a criação do primeiro protocolo para o tratamento desta leucemia, de
Publicado em: 2010
-
6. Estudo de fase I/II de Erlotinib (OZI-774) combinado com radioterapia e cisplatina em pacientes com carcinoma epidermóide de cabeça e pescoço, localmente avançado / Phase I/II study of erlotinib combined with cisplatin and radiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck
Propósito: Erlotinib, um inibidor oral da Tirosina Quinase posicionada junto ao domínio intracelular do EGFR, é uma droga ativa contra Carcinoma de Células Escamosas de Cabeça e Pescoço (CECCP) avançado e possivelmente possui sinergismo com a quimioterapia e radioterapia. O objetivo deste trabalho foi avaliar a dose adequada, a segurança e eficácia
Publicado em: 2009
-
7. Toxicity to chemotherapy treatment in women with breast cancer / Toxicidade ao tratamento quimioterápico em mulheres com câncer de mama
Method: Thais study data were collected retrospectively reviewing the chart of 72 women with breast cancer, underwent to chemotherapy for the first time, that used epirubicin and docetaxel to neoadjuvant treatment and epirubicin and ciclophosphamid to adjuvant treatment. The data collection was done with the charts of women, with 30 to 60 years, treated in 2
Publicado em: 2008
-
8. Avaliação in vivo e in vitro da citotoxicidade, genotoxicidade e dos efeitos protetores de extratos de plantas do cerrado brasileiro
The use of plants for healing purposes is becoming increasingly popular, as soon as they are believed to be beneficial and free of side effects. However, most of information available on several medicinal herbs does not have any scientific supporting data and their use as medicaments is based simply on traditional folk. Among the plants used by the humanity
Publicado em: 2008
-
9. Fatores de risco para mucosite bucal em pacientes com leucemia linfóide aguda submetidos a diferentes protocolos de tratamento / Risk factors to oral mucositis in patients with acute limphoblastic leukemia submitted to different treatment protocols
Oral mucositis is one of the main complications secondary to antineoplastic treatment in patients with acute lymphoblastic leukemia (ALL). The risk factors for its occurrence include age, gender and initial leukocyte count, besides chemotherapeutic drugs with known stomatotoxic action. This study investigated the prevalence and risk factors to oral mucositis
Publicado em: 2006
-
10. Forced evolution of glutathione S-transferase to create a more efficient drug detoxication enzyme.
Glutathione S-transferases (EC 2.5.1.18) in mammalian cells catalyze the conjugation, and thus, the detoxication of a structurally diverse group of electrophilic environmental carcinogens and alkylating drugs, including the antineoplastic nitrogen mustards. We proposed that structural alteration of the nonspecific electrophile-binding site would produce muta